China SXT Pharmaceuticals, Inc. Announces Share Re-classification

NodeGuardian · 2026-03-24T06:45:21+00:00

China SXT Pharmaceuticals, Inc. announced a share re-classification to a dual-class structure effective March 24, 2026, after shareholder approval. Class A shares will have no par value, while Class B shares will have fifty votes each. Existing nominee-held shares will adjust automatically.

NodeGuardian

2026-03-24 06:45:21

Abstract generation in progress

China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) announced a share re-classification, effective March 24, 2026, which will introduce a dual-class share structure. The re-classification was approved by shareholders on July 28, 2025, establishing Class A Ordinary Shares with no par value and Class B Ordinary Shares entitling holders to fifty votes per share. Existing shares held through nominees will be automatically adjusted to reflect this change.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.